WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Luis G. Perla
Associate
Patents and Innovations
Palo Alto
lperla@wsgr.com

D650-849-3351

Download vCard
Open PDF

Dr. Luis G. Perla is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm's patents and innovations practice. Lu focuses on patent prosecution, freedom-to-operate, and due diligence in the fields of organic chemistry, medicinal chemistry, pharmaceuticals, and biotechnology.

Lu conducted his doctoral research at the University of Notre Dame on main group element nanoparticles, specifically organically functionalized Zintl Ions. He focused on the synthetic development of nanoparticle aggregation techniques with an expertise in various physical and computational characterization techniques. Furthermore, he completed a post-doctoral appointment at the University of California, Davis, studying the applications of main-group metal mediated catalysis, i.e., hydrogenation, carbon-carbon cross coupling, via the use of sterically encumbering ligands.

Experience

Dr. Luis G. Perla is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm's patents and innovations practice. Lu focuses on patent prosecution, freedom-to-operate, and due diligence in the fields of organic chemistry, medicinal chemistry, pharmaceuticals, and biotechnology.

Lu conducted his doctoral research at the University of Notre Dame on main group element nanoparticles, specifically organically functionalized Zintl Ions. He focused on the synthetic development of nanoparticle aggregation techniques with an expertise in various physical and computational characterization techniques. Furthermore, he completed a post-doctoral appointment at the University of California, Davis, studying the applications of main-group metal mediated catalysis, i.e., hydrogenation, carbon-carbon cross coupling, via the use of sterically encumbering ligands.

Education
  • J.D., Santa Clara University School of Law, 2024

    High Tech Law Certificate: Intellectual Property Specialization with Honors

  • Ph.D., Chemistry, University of Notre Dame, 2017
  • B.S., Chemistry, St. John's University, 2011
Associations and Memberships
  • American Chemical Society
Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., Santa Clara University School of Law, 2024

    High Tech Law Certificate: Intellectual Property Specialization with Honors

  • Ph.D., Chemistry, University of Notre Dame, 2017
  • B.S., Chemistry, St. John's University, 2011
Associations and Memberships
  • American Chemical Society
Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office

Select Publications

  • Co-author with J.M. Kulenkampff, J.C. Fettinger, and P.P. Power, “Steric and Electronic Properties of the Bulky Terphenyl Ligand ArtBu6 (ArtBu6 = C6H3‑2,6-(C6H2‑2,4,6‑tBu3)2) and Synthesis of Its Tin Derivatives ArtBu6SnCl, ArtBu6SnSn(H)2ArtBu6, and ArtBu6SnSnArtBu6: A New Route to a Distannyne via Thermolysis of the Asymmetric Hydride ArtBu6SnSn(H)2ArtBu6,” 37(21) Organometallics 4048-4054, 2018 
  • Co-author with A. Muñoz-Castro and S.C. Sevov, “Eclipsed- and Staggered-[Ge18Pd3{EiPr3}6]2–(E = Si, Sn): Positional Isomerism in Deltahedral Zintl Clusters,” 139(42) Journal of the American Chemical Society 15176-15181, 2017
  • Co-author with S.C. Sevov, “A Stannyl-Decorated Zintl Ion [Ge18Pd3(SniPr3)6]2–: Twinned Icosahedron with a Common Pd3-Face or 18-Vertex Hypho-Deltahedron with a Pd3-Triangle Inside,” 138(31) Journal of the American Chemical Society 9795-9798, 2016
  • Co-author with S.C. Sevov, “Cluster Fusion: Face‐Fused Nine‐Atom Deltahedral Clusters in [Sn14Ni(CO)]4−,” 55 Angew. Chem. Int. Ed. 6721, 2016
  • Co-author with S.C. Sevov, “[Bi12Ni7(CO)4]4–: Aggregation of Intermetalloid Clusters by Their Thermal Deligation and Oxidation,” 54(17) Inorganic Chemistry 8401-8405, 2015
  • Co-author with A.G. Oliver and S.C. Sevov, “Bi73–: The Missing Family Member, Finally Isolated and Characterized,” 54(3) Inorganic Chemistry 872-875, 2015
Insights

Select Publications

  • Co-author with J.M. Kulenkampff, J.C. Fettinger, and P.P. Power, “Steric and Electronic Properties of the Bulky Terphenyl Ligand ArtBu6 (ArtBu6 = C6H3‑2,6-(C6H2‑2,4,6‑tBu3)2) and Synthesis of Its Tin Derivatives ArtBu6SnCl, ArtBu6SnSn(H)2ArtBu6, and ArtBu6SnSnArtBu6: A New Route to a Distannyne via Thermolysis of the Asymmetric Hydride ArtBu6SnSn(H)2ArtBu6,” 37(21) Organometallics 4048-4054, 2018 
  • Co-author with A. Muñoz-Castro and S.C. Sevov, “Eclipsed- and Staggered-[Ge18Pd3{EiPr3}6]2–(E = Si, Sn): Positional Isomerism in Deltahedral Zintl Clusters,” 139(42) Journal of the American Chemical Society 15176-15181, 2017
  • Co-author with S.C. Sevov, “A Stannyl-Decorated Zintl Ion [Ge18Pd3(SniPr3)6]2–: Twinned Icosahedron with a Common Pd3-Face or 18-Vertex Hypho-Deltahedron with a Pd3-Triangle Inside,” 138(31) Journal of the American Chemical Society 9795-9798, 2016
  • Co-author with S.C. Sevov, “Cluster Fusion: Face‐Fused Nine‐Atom Deltahedral Clusters in [Sn14Ni(CO)]4−,” 55 Angew. Chem. Int. Ed. 6721, 2016
  • Co-author with S.C. Sevov, “[Bi12Ni7(CO)4]4–: Aggregation of Intermetalloid Clusters by Their Thermal Deligation and Oxidation,” 54(17) Inorganic Chemistry 8401-8405, 2015
  • Co-author with A.G. Oliver and S.C. Sevov, “Bi73–: The Missing Family Member, Finally Isolated and Characterized,” 54(3) Inorganic Chemistry 872-875, 2015

Biological Sciences and Biotechnology

  • Cancer therapeutics

Therapeutics and Drug Discovery

  • Drug conjugates
  • Drug delivery
  • Pharmacology
  • Small molecule synthesis
  • Small molecules

Chemistry and Material Science

  • Catalysis
  • Chemical synthesis
  • Chemistry
  • Green chemistry
  • Materials chemistry
  • Organic chemistry
  • Organometallics
  • Peptidomimetics
  • Polymers
  • Polymorph
  • Process chemistry
  • Supramolecular chemistry
Technical Fluency

Biological Sciences and Biotechnology

  • Cancer therapeutics

Therapeutics and Drug Discovery

  • Drug conjugates
  • Drug delivery
  • Pharmacology
  • Small molecule synthesis
  • Small molecules

Chemistry and Material Science

  • Catalysis
  • Chemical synthesis
  • Chemistry
  • Green chemistry
  • Materials chemistry
  • Organic chemistry
  • Organometallics
  • Peptidomimetics
  • Polymers
  • Polymorph
  • Process chemistry
  • Supramolecular chemistry
Focus Areas
  • Patents and Innovations
Recent Insights
Client Highlights
Wilson Sonsini Advises Terremoto on IP Matters Related to $108 Million Series C
On April 15, 2026, Terremoto Biosciences, a biotechnology company developing highly targeted, small molecule medicines, announced the closing of a $108 million Series C financing round. The round includes new investors RA Capital Management, Deep Track Capital, Osage University Partners, and BeOne Medicines, and participation from existing investors OrbiMed, Third Rock Ventures, Novo Holdings, and Cormorant Asset Management. Wilson Sonsini Goodrich & Rosati advised Terremoto on IP matters related to the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Centessa on IP Matters Related to Acquisition by Lilly
On March 31, 2026, Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, announced a definitive agreement for Eli Lilly and Company (Lilly), an American multinational pharmaceutical company, to acquire Centessa. Under the terms of the transaction agreement, Lilly will acquire all of the issued and to be issued share capital of Centessa (including the American Depositary Shares (ADSs) representing ordinary shares) for $38.00 in cash per share plus one non-transferrable contingent value right (CVR) that entitles the holder to receive up to an aggregate of $9.00 subject to the achievement of three milestones described below, for total potential aggregate per share consideration of up to $47.00. The upfront cash consideration represents an aggregate equity value of approximately $6.3 billion and the CVR represents an additional potential aggregate equity value of approximately $1.5 billion. Wilson Sonsini Goodrich & Rosati advised Centessa in IP matters related to the transaction.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.